|
The pandemic has exposed one of the major weaknesses of many supply chains: the inability to react to sudden, large-scale disruptions. This lack of resiliency has been especially notable in the supply chains of the life sciences, health care and food industries. The resulting turmoil has generated calls for companies that had offshore production to Asia (and China, in particular) to bring it back home.
|